Corcept Therapeutics | CORT - Ativo Circulante





Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Alaunos Therapeutics USD 666K 304K 2026-06
ANI Pharmaceuticals USD 902.82M 77.39M 2026-09
Ardelyx USD 441.39M 538K 2026-09
Aurora Cannabis CAD 393.45M 4M 2026-06
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Canopy Growth CAD 506.36M 23.1M 2026-06
Corcept Therapeutics USD 533.87M 94.2M 2026-09
Eli Lilly USD 65.26B 591M 2026-09
J&J USD 56.35B 3.42B 2026-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Merck USD 38.94B 2.26B 2026-09
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 28.75B 1.4B 2026-09
Novartis USD 28.75B 2.14B 2026-09
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 10.3B 9.68B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
TG Therapeutics USD 1.17B 25.76M 2026-09